Congratulations on completing our Launch Readiness Assessment. Please tell us where we can email an initial assessment of your organization’s current launch preparations.
Your diagnostic results show that you are right on track for Launch.
If you enjoyed this survey and are interested in similar tools or conversations related to other aspects of your organization, please feel free to contact SSI Strategy for further discussions - we would be happy to speak with you.
Clinical evidence is the foundation of all successful product launches. One should maximize the amount of evidence generation prior to regulatory submission. If you are finding challenges initiating these processes, SSI can help.
The best data in the world lacks value if it is not appropriately and effectively communicated. The effectiveness of your data dissemination efforts during the pre- and peri-approval phases can make or break the success of your product. If you are finding challenges within your data dissemination plan, SSI can help.
Long gone are the days when your organization’s only Stakeholder is the healthcare professional. The pharmaceutical landscape has greatly shifted such that there are numerous other Stakeholders that must be engaged and satisfied at all stages of the product development life cycle. SSI’s understanding of the landscape both prior to and after the shift can provide immense value in your Stakeholder engagement activities.
Furthermore, an underlying but integral element of launch readiness is Overarching Strategy and Internal Governance. The aspects called out above can only be successful if they are aligned with your organization’s corporate strategy and executed properly under a structured governance model. SSI Strategy is vastly experienced and eminently knowledgeable in this domain, and can offer support and feedback here as well to ensure you are as prepared as possible for a successful launch.